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The magnetization-prepared rapid
gradient-echo (MP-RAGE) T1-weighted
high resolution structural MRI is a main-
stay tool used to identify morphometric
biomarkers of disease conditions, pro-
gression and treatment effects despite a
critical limitation: the relaxation signal
on which inferences are based is nearly
indistinguishable for gray matter vs. blood
flow (Lu et al., 2004; Wright et al., 2008).
Thus, apparent reported morphometric
findings might be at least partially related
to transient changes in blood flow or other
physiological signals.
Consistent with this technical limita-
tion, using a standard analysis technique,
voxel based morphometry (VBM), we
recently reported that a single dose of a
medication had “apparent” effects on T1-
weighted MRIs (Franklin et al., 2013).
Specifically, we observed medication-
induced decreases in gray matter volume
in the anterior cingulate and other regions
that overlapped with changes in brain
blood flow (perfusion). Similarly, oth-
ers have shown effects of medication
on T1-weighted scans that are likely
transient. For example, acute levodopa
administration altered gray matter indices
on T1-weighted images in the midbrain
(Salgado-Pineda et al., 2006). Further, in
a well-controlled longitudinal VBM study
of patients with attention deficit hyper-
activity disorder (ADHD), Hoekzema
et al. (2014) showed that stimulant drugs
trigger transient volumetric changes in
the ventral striatum, challenging previ-
ous VBM studies suggesting that these
changes were an intrinsic feature of the
disorder (Hoekzema et al., 2014). These
examples highlight the importance of
employing appropriate experimental con-
ditions to ensure that morphometric
findings are actually revealing long-term
changes that are unrelated to transient
states. Specifically, longitudinal investiga-
tions into the effects of a medication on
neural structure using VBM may want to
include a group that is administered an
acute dose of the medication.
The findings of altered gray mat-
ter induced by acute pharmacological
manipulations highlighted above led us
to hypothesize that cigarette smoking,
which delivers the psychostimulant, nico-
tine, to the brain may transiently alter
the MP-RAGE, based on the T1-weighted
images. Thus, we examined T1-weighted
structural MRIs acquired in a within-
subjects design in 39 otherwise healthy
nicotine-dependent individuals. Subjects
meeting our standard MRI-specific inclu-
sion/exclusion criteria (Franklin et al.,
2013, 2014) provided written informed
consent to participate in the study, which
adhered to the Declaration of Helsinki
and was approved by the University of
Pennsylvania Institutional Review Board.
Screening procedures included a medi-
cal history, physical examination, and a
psychological assessment. Subjects partic-
ipated in two counterbalanced scanning
sessions that occurred on separate days.
For condition “Smoke” subjects smoked a
cigarette to satiety approximately 45min
prior to obtaining structural MRI data.
For condition “No smoke,” subjects
smoked a cigarette and then remained
abstinent for approximately 5 h prior to
data acquisition. To obtain quantitative
cerebral blood flow (CBF) maps, 5min
resting baseline pseudo-continuous arte-
rial spin labeled perfusion fMRI scans
were also acquired under both conditions.
Nicotine’s terminal half-life is approxi-
mately 2 h; thus, conservative estimates
might place the onset of withdrawal symp-
tomatology within the first 2 h after last
smoking (Benowitz et al., 1982). Thus,
5 h of deprivation was chosen to ensure
that the subjects would be experiencing
withdrawal from nicotine. During the
“No smoke” condition, carbon monox-
ide (CO) levels were acquired after the
baseline cigarette and prior to scanning.
Abstinence was confirmed by monitor-
ing the subjects and was biochemically
confirmed by observing reductions in
CO from baseline to time of scan acqui-
sition. Structural data were analyzed
using statistical mapping software (SPM8)
and its available VBM tool with diffeo-
morphic anatomical registration using
exponentiated lie algebra (DARTEL).
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FIGURE 1 | Illustration of the effects of physiological state on VBM results. T1-weighted
MPRAGE structural MRI scans were acquired in nicotine-dependent individuals after recently
smoking (Smoke condition) or maintaining 5 h of monitored abstinence (No Smoke condition) and
compared. Use of VBM to reveal gray matter indices showed significantly greater gray matter
volume in the Smoke compared to the No Smoke condition in bilateral ventral striatum. Data are
shown overlain on the Montreal Neurological Institute (MNI) template brain using neurological
convention (left is left). X, Y, Z, coordinates shown are from the peak voxel; left, −22 6 −2 [143
voxels, t(37) = 2.93, p = 0.006] and right, 28 8 −2, [423 voxels, t(37) = 3.18, p = 0.003]. The color
bar represents the t-values from the statistical maps (left, T = 3.09; right, T = 3.20).
Statistical parametric maps were generated
to perform between-condition compar-
isons (paired t-test) using the gray matter
tissue segmentation output by DARTEL.
To obtain measures of brain blood flow
mean CBF maps were calculated for each
condition and between-condition com-
parisons (paired t-test) were performed.
Image acquisition, data processing and
analysis methods have been previously
published (Franklin et al., 2013, 2014).
Once again, we report that tran-
sient state impacts gray matter indices.
Compared to not smoking for sev-
eral hours, recent smoking altered
the T-1 weighted MP-RAGE, bilat-
erally in the striatum (see Figure 1
and http://www.franklinbrainimaging.
com/LimitationsofMPRAGE/, which pro-
vides all images from all 3 planes).
Differences were not observed in any other
brain regions. Additionally, as in our pre-
vious study, the effects overlapped with
changes in blood flow (Figure S1 shows
the results from the MP-RAGE and blood
flow overlain on the same template. These
results unambiguously demonstrate that
the use of VBM to identify morphometric
biomarkers of disease conditions, progres-
sion and treatment effects must employ
appropriate experimental conditions to
ensure that morphometric findings are
not related to acute states that may be
introduced by drug or medication, but
are indeed revealing long-term change.
Importantly, the use of medications or
substances (e.g., alcohol, cigarettes, con-
comitant medications) that affect the
brain should be controlled (either through
matching or statistical co-variation) across
groups that are being compared. Third,
these results show that the MP-RAGE
should be acquired at the initiation of a
scanning session, given the potential for
it to be altered by subsequent activities
(tasks, pharmacological manipulations)
that occur over the course of scanning.
These findings also underscore the crucial
and immediate need to develop neu-
roimaging tools that can uniquely capture
changes in neuronal structure dissociable
from those related to blood flow or other
physiological signals.
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Figure S1 | Illustration of the overlap
between MP-RAGE and blood flow results.
Representative coronal [left above and
below (enlarged)] and sagittal (right) images
showing the regions of increased blood flow
(blue) and the structural alterations (red) and
the overlap between them (purple) in the
sated vs. withdrawal conditions. P-value is
set at 0.05 for display. Blood flow and
structural data were analyzed in SPM8 and
overlain on the MNI brain.
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